The economic burden of angina in women with suspected ischemic heart disease: Results from the National Institutes of Health-National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation

Circulation

Volumn 114, Issue 9, 2006, Pages 894-904

  Shaw, Leslee J ^a,j   Merz, C Noel Bairey ^a   Pepine, Carl J ^b   Reis, Steven E ^c   Bittner, Vera ^g   Kip, Kevin E ^d   Kelsey, Sheryl F ^d   Olson, Marian ^d   Johnson, B Delia ^d   Mankad, Sunil ^e   Sharaf, Barry L ^f   Rogers, William J ^g   Pohost, Gerald M ^h   Sopko, George ⁱ  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^d UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^e DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^f RHODE ISLAND HOSPITAL   (United States)

^g University of Alabama at Birmingham and Birmingham Veterans Affairs Medical Center   (United States)

^h UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

ⁱ NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^j EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Angina; Angiography; Coronary disease; Cost benefit analysis; Prognosis; Women

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANXIOLYTIC AGENT; CARDIOVASCULAR AGENT;

ADULT; AGED; AMBULATORY CARE; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ANXIETY DISORDER; ARTICLE; CARDIOVASCULAR SYSTEM; CLINICAL ASSESSMENT; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; COST BENEFIT ANALYSIS; DEATH; DEPRESSION; DIABETES MELLITUS; DRUG USE; FEMALE; FOLLOW UP; GENDER; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HEALTH ECONOMICS; HEART CATHETERIZATION; HEART INFARCTION; HORMONE SUBSTITUTION; HOSPITALIZATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INFORMATION PROCESSING; ISCHEMIC HEART DISEASE; LIFESPAN; MAJOR CLINICAL STUDY; PALLIATIVE THERAPY; PATIENT REFERRAL; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PRODUCTIVITY; PROGNOSIS; PROSPECTIVE STUDY; STATISTICAL ANALYSIS; SYMPTOMATOLOGY; THORAX PAIN; TRAVEL;

AGED; ANGINA PECTORIS; CORONARY ANGIOGRAPHY; COST OF ILLNESS; FEMALE; HUMANS; MENOPAUSE; MIDDLE AGED; MITRAL VALVE PROLAPSE; MYOCARDIAL ISCHEMIA; NATIONAL INSTITUTES OF HEALTH (U.S.); OBESITY; SMOKING; SOCIOECONOMIC FACTORS; SYNDROME; UNITED STATES; WOMEN;

EID: 33748367878     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.105.609990     Document Type: Article

References (49)

1. Merrill CT, Elixhauser A. Procedures in U.S. hospitals, 2003. Available at: http://www.ahrq.gov/data/hcup/factbk7/factbk7.pdf. Accessed August 16, 2006.
2. Centers for Disease Control. Chronic disease overview. Available at: http://www.cdc.gov/nccdphp/overview.htm. Accessed July 4, 2004.
3. Barendregt JJ, Bonneuz L, van der Maas PJ. The health care costs of smoking. N Engl J Med. 1997;337:1052-1057.
4. Daviglus ML, Liu K, Greenland P, Dyer AR, Garside DB, Manheim L, Lowe LP, Rodin M, Lubitz J, Stamler J. Benefit of a favorable cardiovascular risk-factor profile in middle age with respect to Medicare costs. N Engl J Med. 1998;339:1122-1129.
5. Mustard CA, Kaufert P, Kozyrskyj A, Mayer T. Sex differences in the use of health care services. N Engl J Med. 1998;338:1678-1683.
6. Haas J. The cost of being a woman. N Engl J Med. 1998;338:1694-1695.
7. Raine R, Hutchings A, Black N. Is publicly funded health care really distributed according to need? Health Policy. 2004;67:227-235.
8. American Heart Association. Heart disease and stroke statistics: 2004 update. Available at: http://www.americanheart.org/downloadable/heart/ 1079736729696HDSStats2004UpdateREV3-19-04.pdf. Accessed July 4, 2004.
9. Jiang HJ, Elixhauser A, Nicholas J, Steiner C, Reyes C, Beiman AS. Care of women in U.S. hospitals, 2000. Available at: http://www.ahrq.gov/data/hcup/ factbk3/factbk3.pdf. Accessed August 16, 2006.
10. Hemingway H, Crook AM, Feder G, Banerjee S, Dawson JR, Magee P, Philpott S, Sanders J, Wood A, Timmis SD. Underuse of coronary revascularization procedures in patients considered appropriate candidates for revascularization. N Engl J Med. 2001;344:645-654.
11. Merz NB, Johnson BD, Kelsey PSF, Reis SE, Lewis JF, Reichek N, Rogers WJ, Pepine CF, Shaw LJ, for the WISE Study Group. Diagnostic, prognostic, and cost assessment of coronary artery disease in women. Am J Manag Care. 2001;7:959-965.
12. Manheim L, Lowe LP, Rodin M, Lubitz J, Stamler J. Benefit of a favorable cardiovascular risk-factor profile in middle age with respect to Medicare costs. N Engl J Med. 1998;339:1122-1129.
13. Mark DB, Shaw LJ, Lauer MS, O'Malley P, Heidenreich P. 34th Bethesda Conference: Task Force #5: is atherosclerotic imaging cost effective? From the 34th Bethesda Conference on Atherosclerotic Imaging. J Am Coll Cardiol. 2003;41:1906-1917.
14. Stewart WF, Ricci JA, Chee E, Morganstein D, Lipton R. Lost productive time and cost due to common pain conditions in the US workforce. JAMA. 2003;290:2443-2454.
15. Birnbaum J, Leong S, Kabra A. Lifetime medical costs for women: cardiovascular disease, diabetes, and stress urinary incontinence. Womens Health Issues. 2003;13:204-213.
16. Shaw LJ, Heller GV, Travin MI, Lauer M, Marwick TH, Hachamovitch R, Berman DS, Miller DD. Cost analysis of diagnostic testing for coronary artery disease in women with stable chest pain. J Nucl Cardiol. 1999;6:559-569.
17. Bairey Merz CN, Kelsey SF, Pepine CJ, Reichek N, Reis SE, Rogers WJ, Sharaf BL, Sopko G. The Women's Ischemia Syndrome Evaluation (WISE) study: protocol design, methodology and feasibility report. J Am Coll Cardiol. 1999;33:1453-1461.
18. Bairey Merz N, Bonow RO, Sopko G, Balaban RS, Cannon RO III, Gordon D, Hand MM, Hayes SN, Lewis JF, Long T, Manolio TA, Maseri A, Nabel EG, Nickens PD, Pepine CJ, Redberg RF, Rossouw JE, Selker HP, Shaw LJ, Waters DD, endorsed by the American College of Cardiology Foundation. Women's Ischemic Syndrome Evaluation: current status and future research directions: report of the National Heart, Lung and Blood Institute Workshop: October 2-4, 2002: executive summary. Circulation. 2004;109:805-807.
19. Hlatky MA, Boineau RE, Higginbotham MB, Lee KL, Mark DB, Califf RM, Cobb FR, Pryor DB. A brief self-administered questionnaire to determine functional capacity. Am J Cardiol. 1989;64:651-644.
20. Bairey Merz CN, Olson M, McGorray S, Pakstis DL, Zell K, Rickens CR, Kelsey SF, Bittner V, Sharaf BL, Sopko G. Physical activity and functional capacity measurement in women. J Womens Health Gend Based Med. 2000;9:769-777.
21. Sharaf BL, Pepine CJ, Kerensky RA, Reis SE, Reichek N, Rogers WJ, Sopko G, Kelsey SF, Holubkov R, Olson M, Miele NJ, Williams DO, Merz CN, for the WISE Study Group. Detailed angiographic analysis of women with suspected ischemic chest pain. Am J Cardiol. 2001;87:937-941.
22. Mahoney EM, Jurkovitz CT, Chu H, Becker ER, Culler S, Kosinski AS, Robertson DH, Alexander C, Nag S, Cook JR, Demopoulos LA, DiBattiste PM, Cannon CP, Weintraub WS. Cost and cost-effectiveness of an early invasive vs conservative strategy for the treatment of unstable angina and non-ST-segment elevation myocardial infarction. JAMA. 2002;288:1851-1858.
23. Johnson BD, Shaw LJ, Buchthal SD, Bairey Merz CN, Kim HW, Scott KN, Doyle M, Olson MB, Pepine CJ, den Hollander J, Sharaf B, Rogers WJ, Mankad S, Forder JR, Kelsey SF, Pohost GM. Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease. Circulation. 2004;109:2993-2999.
24. Shaw LJ, Lewis JF, Hlatky MA, Hsueh WA, Kelsey SF, Klein R, Manolio TA, Sharrett AR, Tracy RP; National Heart, Lung, and Blood Institute, American College of Cardiology Foundation. Women's Ischemia Syndrome Evaluation. Circulation. 2004;109:e56-e58.
25. Gold M. Cost-Effectiveness in Health and Medicine. New York, NY: Oxford University Press; 1996.
26. Buxton MJ, Drummond MF, Van Hout BA, Prince RL, Sheldon TA, Szues T, Vray M. Modeling in economic evaluation: an unavoidable fact of life. Health Econ. 1997;6:217-227.
27. Smith DH, Gravelle H. The practice of discounting in economic evaluations of healthcare interventions. Int J Tech Assess Health Care. 2001;17:236-243.
28. Russell LB, Gold MR, Siegel JE, Daniels N, Weinstein MC. The role of cost-effectiveness analysis in health and medicine: Panel on Cost-Effectiveness in Health and Medicine. JAMA. 1996;276:1172-1177.
29. Mark DB, Hlatky MA. Medical economics in the assessment of value in cardiovascular medicine, part I. Circulation. 2002;106:516-520.
30. Mark DB, Hlatky MA. Medical economics in the assessment of value in cardiovascular medicine, part II. Circulation. 2002;106:626-630.
31. Sheldon TA. Discounting in health care decision-making: time for a change? J Pub Health Med. 1992;14:250-256.
32. Pennell DJ, Sechtem UP, Higgins CB, Manning WJ, Pohost GM, Rademakers FE, van Rossum AC, Shaw LJ, Yucel EK; Society for Cardiovascular Magnetic Resonance; Working Group on Cardiovascular Magnetic Resonance of the European Society of Cardiology. Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. Eur Heart J. 2004;25:1940-1965.
33. Thomson Healthcare. PDR bookstore. Available at: http://www.pdrbookstore. com. Accessed July 4, 2004.
34. US Department of Labor, Bureau of Labor Statistics. Consumer Price Index home page. Available at: http://www.bls.gov/cpi/home.htm#data. Accessed August 16, 2006.
35. Mathers CD, Sadana R, Salomon JA, Murray CJL, Lopez AD. Estimates of DALE for 191 countries: methods and results. Available at: http://www.who.int/ health-systems-performance/docs/article/paper16a.pdf. Accessed July 5, 2004.
36. World Health Organization. Cardiovascular disease atlas. Available at: http://www.who.int/cardiovascular_diseases/en/cvd_atlas_17_economics.pdf. Accessed March 22, 2006.
37. Bairey Merz CN, Shaw LJ, Reis SE, Kelsey SF, Olson M, Johnson BD, Pepine CJ, Mankad S, Sharaf BL, Rogers WJ, Pohost GM, Sopko G. Ischemic heart disease in women: insights from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study. J Am Coll Cardiol. 2006;47:S21-S29.
38. Alemayehu B, Warner KE. The lifetime distribution of health care costs. Health Serv Res. 2004;29:627-642.
39. American College of Cardiology. 2005 Proposed physician payment rules. Available at: http://www.acc.org/advocacy/word_files/ 2005ProposedPhysicianPmtRulev3%20web.xls. Accessed November 10, 2005.
40. Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, Ferguson TB Jr, Fihn SD, Fraker TD Jr, Gardin JM, O'Rourke RA, Pasternak RC, Williams SV. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for the Management of Patients with Chronic Stable Angina). 2002. Available at: http://www.acc.org/clinical/guidelines/stable/stable.pdf. Accessed August 16, 2006.
41. Shugarman LR, Campbell DE, Bird CE, Gabel J, Louis AT, Lynn J. Differences in Medicare expenditures during the last 3 years of life. J Gen Int Med. 2004;19:127-135.
42. Birnbaum H, Leong S, Kabra A. Lifetime medical costs for women: cardiovascular disease, diabetes, and stress urinary incontinence. Womens Health Issues. 2003;13:204-213.
43. Pukk K, Lundberg J, Penaloza-Pesantes RV, Brommels M, Gaffney FA. Do women simply complain more? National patient injury claims data show gender and age differences. Qual Manag Health Care. 2003;12:225-231.
44. Doyal L. Gender and the 10/90 gap in health research. Bull World Health Organ. 2004;82:162.
45. Barbeau EM, Krieger N, Soobader MJ. Working class matters: socioeconomic disadvantage, race/ethnicity, gender, and smoking in NHIS 2000. Am J Public Health. 2004;94:269-278.
46. Richardson J. Gender differences associated with physical functioning in older persons with angina. Disabil Rehabil. 2003;25:973-983.
47. Krieger N, Chen JT, Waterman PD, Rehkopf DH, Subramanian SV. Race/ethnicity, gender, and monitoring socioeconomic gradients in health. Am J Public Health. 2003;93:1655-1671.
48. Wrobel MV, Doshi J, Stuart BC, Briesacher B. Predictability of prescription drug expenditures for Medicare beneficiaries. Health Care Finance Rev. 2003;25:37-46.
49. Rao SV, Kaul P, Newby LK, Lincoff AM, Hochman J, Harrington RA, Mark DB, Peterson ED. Poverty, process of care, and outcome in acute coronary syndromes. J Am Coll Cardiol. 2003;41:1948-1954.